Companies: 10,795·Total market cap: $144.5T

Passage Bio, Inc.

Passage Bio, Inc.

PASGNASDAQHealthcare● Active

$5.60

+$0.13(+2.38%)

Market Cap$17963736

P/E Ratio—

52W High$20

52W Low$3.935

Avg Volume79K

Open$5.52

Beta1.41

Net Income Financials Revenue

Passage Bio, Inc. (PASG) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

PASG · net income · updated Jun 9, 2026

Core profitability metrics

PASG · net income · margin · TTM · CAGR

Net income was −$45.5M for FY2025 (fiscal year ending 2025-12-31), up 29.7% year-over-year. Net profit margin was —.

FY2025 Net Income−$45.5M▲ +29.7% YoY

Trailing 12M (TTM)—trailing 4 quarters sum

Net Profit Margin——

YoY Change+29.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · PASG net income history · PASG profit margin

Annual net income data

PASG · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$45.5M▲ +29.7%—$0

FY2024Loss−$64.8M▲ +36.5%—$0

FY2023Loss−$102.1M▲ +25.0%—$0

FY2022Loss−$136.1M▲ +26.6%—$0

FY2021Loss−$185.4M▼ 65.2%—$0

Net income vs peers (Healthcare)

PASG vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Passage Bio, Inc. (PASG) reported net income of −$45.5M for FY2025 (fiscal year ending 2025-12-31), up 29.7% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Passage Bio, Inc. has not yet achieved annual profitability based on available data (8 fiscal years). The company has reported net losses across all available periods.

Passage Bio, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Passage Bio, Inc. net worth" — the company's market capitalization is a separate figure from PASG net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

PASG net income · 4 questions

Passage Bio, Inc. is not currently profitable on an annual basis. The company reported a net loss of $45.5M for FY2025.

is PASG profitabledoes PASG make a profitPASG profitabilityPASG profitable company

▸ Source: FMP /income-statement · GAAP · Passage Bio, Inc. · Passage Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026